Carboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer?
作者信息
Markman M
出版信息
J Cancer Res Clin Oncol. 1996;122(8):443-4. doi: 10.1007/BF01187154.
Abstract
摘要
相似文献
1
Carboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer?卡铂和顺铂：在“最佳残留”晚期卵巢癌中它们的疗效等效吗？
J Cancer Res Clin Oncol. 1996;122(8):443-4. doi: 10.1007/BF01187154.
2
Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗。晚期卵巢癌试验组。
Cochrane Database Syst Rev. 2000(2):CD001418. doi: 10.1002/14651858.CD001418.
3
Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin.
Tumori. 1999 Jul-Aug;85(4):297-8. doi: 10.1177/030089169908500418.
4
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases.
Tumori. 2003 May-Jun;89(3):311-3. doi: 10.1177/030089160308900315.
5
[Carboplatin--well tolerated and effective].[卡铂——耐受性良好且疗效显著]
Radiologe. 1998 Jul;38(7 Suppl):1-8.
6
In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study.用于预测上皮性卵巢癌临床结局的紫杉烷类或铂类化合物体外极端耐药性检测：一项前瞻性队列研究
J Cancer Res Clin Oncol. 2009 Nov;135(11):1513-20. doi: 10.1007/s00432-009-0598-0. Epub 2009 May 16.
7
"Recurrence within 6 months of platinum therapy": an adequate definition of "platinum-refractory" ovarian cancer?
Gynecol Oncol. 1998 May;69(2):91-2. doi: 10.1006/gyno.1998.4997.
8
Carboplatin versus cisplatin in solid tumors: an analysis of the literature.卡铂与顺铂治疗实体瘤的疗效对比：文献分析
Ann Oncol. 1998 Jan;9(1):13-21. doi: 10.1023/a:1008215213739.
9
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
10
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.顺铂与卡铂的比较药理学及临床活性综述。
J Clin Oncol. 1999 Jan;17(1):409-22. doi: 10.1200/JCO.1999.17.1.409.
本文引用的文献
1
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.足叶乙苷和顺铂对比足叶乙苷和卡铂治疗低危生殖细胞肿瘤患者的随机试验：一项多机构研究
J Clin Oncol. 1993 Apr;11(4):598-606. doi: 10.1200/JCO.1993.11.4.598.
2
Advanced ovarian cancer. Carboplatin versus cisplatin.晚期卵巢癌。卡铂与顺铂的对比。
Ann Oncol. 1993;4 Suppl 4:41-8.
3
Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer.顺铂与卡铂治疗晚期上皮性卵巢癌的第一项随机研究的长期随访
J Clin Oncol. 1994 Oct;12(10):2066-70. doi: 10.1200/JCO.1994.12.10.2066.
4
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
J Natl Cancer Inst. 1989 Oct 4;81(19):1464-71. doi: 10.1093/jnci/81.19.1464.
5
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.卡铂、多柔比星与环磷酰胺对比顺铂、多柔比星与环磷酰胺：一项III-IV期上皮性卵巢癌的随机试验
J Clin Oncol. 1991 Apr;9(4):658-63. doi: 10.1200/JCO.1991.9.4.658.
6
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗：随机临床试验综述。晚期卵巢癌试验协作组
BMJ. 1991 Oct 12;303(6807):884-93. doi: 10.1136/bmj.303.6807.884.
7
Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.顺铂-环磷酰胺与卡铂-环磷酰胺治疗晚期卵巢癌的疗效比较：加拿大国家癌症研究所临床试验组的一项随机III期研究
J Clin Oncol. 1992 May;10(5):718-26. doi: 10.1200/JCO.1992.10.5.718.
8
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.卡铂联合环磷酰胺对比顺铂联合环磷酰胺的治疗指数提高：西南肿瘤协作组关于 III 期和 IV 期卵巢癌 III 期随机试验的最终报告
J Clin Oncol. 1992 May;10(5):706-17. doi: 10.1200/JCO.1992.10.5.706.
Zotero 插件